Orthopaedics: Market Prospects & Global Competition
NEW YORK, Dec. 13, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Orthopaedics: Market Prospects & Global Competition
http://www.reportlinker.com/p01054660/Orthopaedics-Market-Prospects--Global-Competition .html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Orthopedic
Growth in the global orthopaedic market is projected to be 8% over the period 2012-17. By 2017, orthopaedic revenues are expected to total US$51.1 billion compared with US$34.7 billion in 2012 - but which companies are driving this growth?
The orthopaedic market has not been immune to the economic downturn that has plagued world economies in recent times. Some of the smaller companies, particularly those at the cutting edge of the market, found themselves short of cash and with little in the way of white knights to help make up the shortfall.
Now things are slowly changing. Private equity has returned to the industry and some of those calls for cash are finally getting answered by investors. It has become noticeable that a number of these investors have been able to successfully sell some of their business holdings with their pride relatively intact. And the reasons why we need these devices are growing ever more present.
The strength of the orthopaedics sector is that the fundamentals remain strong. It is one of the fastest growing sectors in the industry, thanks to the impact of an expanding elderly population and the associated steady rise and diagnosis in musculoskeletal disorders.
Use this new report to easily answer key business questions such as:
What developments will underpin the 2012-17 CAGR of 8.2% in the artificial joint sector?
What new products and services has Integra LifeSciences introduced in 2012?
What is the product and service line of the newly merged DePuy Synthes?
What are the latest developments in worldwide regulation and how are they affecting the orthopaedic sector?
Does ConforMIS patented i-fit technology signal progression on the development of bespoke, patient specific implants?
Which company posted flat sales in the US but grew revenues in Europe and Asia by 10% and 16% respectively in 2011?
Who is active in the foot and ankle ortho sector and what are their competing products?
A complete analysis packed with facts, forecasts and
detailed company evaluations
Regulation: First Approval – why some companies prefer Europe over the USA
There is increasing concern from manufacturers that access to the world's largest orthopaedic market is being frustrated by the FDA's lengthy and costly approval process. Some companies have made conscious efforts to avoid the US market, citing the expense and uncertainty of the FDA process as the reasons. Indeed, it is often seen as a preferred option for US start-ups to find their feet - and their revenues - in the European market. Faced without the possibility of much needed revenue, a massive regulatory bill and a nervy team of investors, companies eyeing the US market are required to sit tight as the FDA goes through its safety and efficacy review processes.
Study shows the contrasts
The contrast in regulatory approaches in Europe could not be clearer. According to a 2010 Stanford University study in the US, entitled "FDA Impact on US Medical Technology Innovation, for a PMAtype product, the time span from the initial contact with the regulatory authority until market launch amounted to 54 months in the US, compared with 11 months in Europe. On average, a market launch in Europe can be realised three years earlier, with significantly lower costs. Financially, it can take a device manufacturer three to five years to get a medical device approved in Japan and China, at a cost of US$3 million or less in each market. In Europe, the time can range from six months to two years and cost around US$2 million. In contrast, getting approval in the US for a medical device can take between two and seven years and cost between US$50 to US$100 million. Time frames differ for those pursuing the 510(k) route to approval, but even here the FDA's anxieties can be seen in requests for further information after first review: 3 out of 4 applications will now be referred back to the company. The trend, illustrated in the chart below, shows that this is long established.
CONTENTS
INTRODUCTION..1
AN OVERVIEW OF REGULATORY ISSUES IN THE US, EUROPE AND BEYOND ..3
ORTHOPAEDIC COMPANIES FIVE-YEAR SALES REVIEW.23
AAP IMPLANTATE25
KEY PERSONNEL..25
COMPANY OVERVIEW .25
KEY MILESTONES 25
AGREEMENTS.26
TECHNOLOGIES/PRODUCTS27
KEY FINANCIAL DATA30
ALPHATEC SPINE.31
KEY PERSONNEL..31
COMPANY OVERVIEW .31
KEY COMPETITORS 31
KEY MILESTONES 31
AGREEMENTS.32
TECHNOLOGIES/PRODUCTS34
KEY FINANCIAL DATA41
AMEDICA..43
KEY PERSONNEL..43
COMPANY OVERVIEW .43
KEY MILESTONES 43
AGREEMENTS 44
TECHNOLOGIES/PRODUCTS45
KEY FINANCIAL DATA47
ANIKA THERAPEUTICS 49
KEY PERSONNEL..49
COMPANY OVERVIEW .49
KEY COMPETITORS 49
KEY MILESTONES 49
AGREEMENTS.50
R&D MILESTONES ..50
TECHNOLOGIES/PRODUCTS50
KEY FINANCIAL DATA51
ARTHROCARE 53
KEY PERSONNEL..53
COMPANY OVERVIEW .53
KEY COMPETITORS 53
KEY MILESTONES 53
AGREEMENTS.54
R&D MILESTONES ..54
TECHNOLOGIES/PRODUCTS55
KEY FINANCIAL DATA63
ARTIMPLANT 65
KEY PERSONNEL. 65
COMPANY OVERVIEW 65
KEY MILESTONES .. 65
AGREEMENTS 65
R&D MILESTONES .66
TECHNOLOGIES/PRODUCTS.. 67
KEY FINANCIAL DATA.. 67
BACTERIN INTERNATIONAL 69
KEY PERSONNEL. 69
COMPANY OVERVIEW 69
KEY COMPETITORS .. 69
KEY MILESTONES .. 69
AGREEMENTS 70
R&D MILESTONES . 70
TECHNOLOGIES/PRODUCTS.. 71
KEY FINANCIAL DATA.. 71
BIOMET. 73
KEY PERSONNEL. 73
COMPANY OVERVIEW 73
KEY COMPETITORS .. 73
KEY MILESTONES .. 74
AGREEMENTS 74
R&D MILESTONES . 75
TECHNOLOGIES/PRODUCTS.. 76
SUBSIDIARIES 81
KEY FINANCIAL DATA..88
BIOMIMETIC THERAPEUTICS. 89
KEY PERSONNEL.89
COMPANY OVERVIEW 89
KEY COMPETITORS ..89
KEY MILESTONES ..89
AGREEMENTS 91
R&D MILESTONES . 91
TECHNOLOGIES/PRODUCTS.. 93
KEY FINANCIAL DATA..94
BONESUPPORT 95
KEY PERSONNEL. 95
COMPANY OVERVIEW 95
KEY COMPETITORS .. 95
KEY MILESTONES .. 95
AGREEMENTS 95
TECHNOLOGIES/PRODUCTS..96
KEY FINANCIAL DATA.. 97
CAYENNE MEDICAL.. 99
KEY PERSONNEL.99
COMPANY OVERVIEW 99
KEY MILESTONES ..99
AGREEMENTS99
R&D MILESTONES ..100
PRODUCTS ..100
KEY FINANCIAL DATA 101SEPTEMBER 2012 ESPICOM BUSINESS INTELLIGENCE V
ORTHOPAEDICS: MARKET PROSPECTS & GLOBAL COMPETITION TABLE OF CONTENTS
CO.DON . 103
KEY PERSONNEL..103
COMPANY OVERVIEW .103
KEY COMPETITORS 103
AGREEMENTS.103
R&D MILESTONES ..104
TECHNOLOGIES/PRODUCTS104
KEY FINANCIAL DATA104
CONFORMIS 105
KEY PERSONNEL..105
COMPANY OVERVIEW .105
KEY MILESTONES 105
AGREEMENTS.106
TECHNOLOGIES/PRODUCTS106
KEY FINANCIAL DATA106
CORIN..107
KEY PERSONNEL..107
COMPANY OVERVIEW .107
KEY MILESTONES 107
AGREEMENTS.107
R&D MILESTONES ..108
TECHNOLOGIES/PRODUCTS108
KEY FINANCIAL DATA.111
DEPUY SYNTHES ..113
KEY PERSONNEL113
COMPANY OVERVIEW ..113
KEY COMPETITORS .114
KEY MILESTONES .115
AGREEMENTS..116
TECHNOLOGIES/PRODUCTS.117
KEY FINANCIAL DATA134
DJO GLOBAL 135
KEY PERSONNEL.. 135
COMPANY OVERVIEW . 135
KEY COMPETITORS 135
KEY MILESTONES 135
AGREEMENTS 136
R&D MILESTONES .. 137
TECHNOLOGIES/PRODUCTS 137
KEY FINANCIAL DATA 147
EXACTECH.149
KEY PERSONNEL..149
COMPANY OVERVIEW .149
KEY COMPETITORS 149
KEY MILESTONES 149
AGREEMENTS.150
R&D MILESTONES .. 151
TECHNOLOGIES/PRODUCTS 151
KEY FINANCIAL DATA 157
GLOBUS MEDICAL159
KEY PERSONNEL.. 159
COMPANY OVERVIEW . 159
KEY COMPETITORS 159
KEY MILESTONES 159
R&D MILESTONES ..160
TECHNOLOGIES/PRODUCTS 161
KEY FINANCIAL DATA165
HANGER .167
KEY PERSONNEL.. 167
COMPANY OVERVIEW . 167
KEY COMPETITORS 167
KEY MILESTONES 167
AGREEMENTS.168
R&D MILESTONES ..168
TECHNOLOGIES/PRODUCTS169
KEY FINANCIAL DATA 171
INION173
KEY PERSONNEL.. 173
COMPANY OVERVIEW . 173
KEY MILESTONES 173
AGREEMENTS. 173
R&D MILESTONES 174
TECHNOLOGIES/PRODUCTS.174
KEY FINANCIAL DATA 176
INTEGRA LIFESCIENCES177
KEY PERSONNEL.. 177
COMPANY OVERVIEW . 177
KEY COMPETITORS 177
KEY MILESTONES 177
AGREEMENTS. 181
TECHNOLOGIES/PRODUCTS 181
KEY FINANCIAL DATA 191
K2M193
KEY PERSONNEL.. 193
COMPANY OVERVIEW . 193
KEY MILESTONES 193
AGREEMENTS.195
TECHNOLOGIES/PRODUCTS195
KEY FINANCIAL DATA 197
KANGHUI MEDICAL .. 199
KEY PERSONNEL..199
COMPANY OVERVIEW .199
KEY COMPETITORS 199
KEY MILESTONES 199
AGREEMENTS.200
TECHNOLOGIES /PRODUCTS..200
KEY FINANCIAL DATA202SEPTEMBER 2012 ESPICOM BUSINESS INTELLIGENCE VII
ORTHOPAEDICS: MARKET PROSPECTS & GLOBAL COMPETITION TABLE OF CONTENTS
KFX MEDICAL. 203
KEY PERSONNEL..203
COMPANY OVERVIEW .203
KEY COMPETITORS 203
KEY MILESTONES 203
TECHNOLOGIES/PRODUCTS204
KEY FINANCIAL DATA204
KUROS BIOSURGERY 205
KEY PERSONNEL..205
COMPANY OVERVIEW .205
KEY MILESTONES 205
AGREEMENTS.205
R&D MILESTONES ..206
TECHNOLOGIES/PRODUCTS207
KEY FINANCIAL DATA208
LANX 209
KEY PERSONNEL..209
COMPANY OVERVIEW .209
KEY MILESTONES 209
AGREEMENTS.209
R&D MILESTONES .. 210
TECHNOLOGIES/PRODUCTS 210
KEY FINANCIAL DATA.211
LDR SPINE .213
KEY PERSONNEL.. 213
COMPANY OVERVIEW . 213
KEY COMPETITORS 213
KEY MILESTONES 213
R&D MILESTONES .. 214
TECHNOLOGIES/PRODUCTS 215
KEY FINANCIAL DATA 217
LIFE SPINE.219
KEY PERSONNEL.. 219
COMPANY OVERVIEW . 219
KEY MILESTONES 219
AGREEMENTS.220
TECHNOLOGIES/PRODUCTS220
KEY FINANCIAL DATA222
MAKO SURGICAL. 223
KEY PERSONNEL..223
COMPANY OVERVIEW .223
KEY COMPETITORS 223
KEY MILESTONES 223
AGREEMENTS.224
R&D MILESTONES ..224
TECHNOLOGIES/PRODUCTS224
KEY FINANCIAL DATA226VIII
TABLE OF CONTENTS ORTHOPAEDICS: MARKET PROSPECTS & GLOBAL COMPETITION
MAZOR ROBOTICS . 227
KEY PERSONNEL..227
COMPANY OVERVIEW .227
KEY MILESTONES 227
AGREEMENTS.228
R&D MILESTONES ..228
TECHNOLOGIES/PRODUCTS229
KEY FINANCIAL DATA230
MEDICREA INTERNATIONAL 231
KEY PERSONNEL..231
COMPANY OVERVIEW .231
KEY MILESTONES 231
AGREEMENTS.231
R&D MILESTONES ..232
TECHNOLOGIES/PRODUCTS232
KEY FINANCIAL DATA233
MEDTRONIC 235
KEY PERSONNEL..235
COMPANY OVERVIEW .235
KEY COMPETITORS 235
KEY MILESTONES 236
AGREEMENTS.238
R&D MILESTONES ..239
TECHNOLOGIES/PRODUCTS240
KEY FINANCIAL DATA248
NUVASIVE 249
KEY PERSONNEL..249
COMPANY OVERVIEW .249
KEY COMPETITORS 249
KEY MILESTONES 250
AGREEMENTS.251
R&D MILESTONES ..251
TECHNOLOGIES/PRODUCTS252
KEY FINANCIAL DATA254
ORTHOFIX INTERNATIONAL. 255
KEY PERSONNEL..255
COMPANY OVERVIEW .255
KEY COMPETITORS 255
KEY MILESTONES 256
AGREEMENTS.257
TECHNOLOGIES/PRODUCTS258
KEY FINANCIAL DATA264
PIONEER SURGICAL TECHNOLOGY. 265
KEY PERSONNEL..265
COMPANY OVERVIEW .265
KEY MILESTONES 265
AGREEMENTS.266
R&D MILESTONES ..267
TECHNOLOGIES/PRODUCTS267
KEY FINANCIAL DATA270SEPTEMBER
RTI BIOLOGICS.. 271
KEY PERSONNEL..271
COMPANY OVERVIEW .271
KEY MILESTONES 271
AGREEMENTS.272
R&D MILESTONES ..272
TECHNOLOGIES/PRODUCTS273
KEY FINANCIAL DATA276
SI-BONE. 277
KEY PERSONNEL..277
COMPANY OVERVIEW .277
KEY COMPETITORS 277
KEY MILESTONES 277
R&D MILESTONES ..278
TECHNOLOGIES/PRODUCTS278
KEY FINANCIAL DATA278
SMALL BONE INNOVATIONS 279
KEY PERSONNEL..279
COMPANY OVERVIEW .279
KEY COMPETITORS 279
KEY MILESTONES 279
AGREEMENTS.280
R&D MILESTONES ..281
TECHNOLOGIES/PRODUCTS281
KEY FINANCIAL DATA284
SMITH & NEPHEW .. 285
KEY PERSONNEL..285
COMPANY OVERVIEW .285
KEY COMPETITORS 285
KEY MILESTONES 286
AGREEMENTS 287
R&D MILESTONES ..288
TECHNOLOGIES/PRODUCTS289
KEY FINANCIAL DATA292
SPINAL ELEMENTS . 295
KEY PERSONNEL..295
COMPANY OVERVIEW .295
KEY COMPETITORS 295
KEY MILESTONES 295
AGREEMENTS 295
R&D MILESTONES ..296
TECHNOLOGIES/PRODUCTS296
KEY FINANCIAL DATA297
SPINALMOTION 299
KEY PERSONNEL..299
COMPANY OVERVIEW .299
KEY MILESTONES 299
R&D MILESTONES ..299
TECHNOLOGIES/PRODUCTS300
KEY FINANCIAL DATA300X
SPINESMITH 301
KEY PERSONNEL..301
COMPANY OVERVIEW .301
KEY MILESTONES 301
AGREEMENTS.301
R&D MILESTONES ..302
TECHNOLOGIES/PRODUCTS302
KEY FINANCIAL DATA303
STANMORE IMPLANTS 305
KEY PERSONNEL..305
COMPANY OVERVIEW .305
KEY MILESTONES 305
AGREEMENTS.305
TECHNOLOGIES/PRODUCTS306
KEY FINANCIAL DATA308
STRYKER 309
KEY PERSONNEL..309
COMPANY OVERVIEW .309
KEY COMPETITORS 309
KEY MILESTONES 310
AGREEMENTS..311
R&D MILESTONES 311
TECHNOLOGIES/PRODUCTS 312
KEY FINANCIAL DATA320
SYMMETRY MEDICAL 321
KEY PERSONNEL.. 321
COMPANY OVERVIEW . 321
KEY COMPETITORS 321
KEY MILESTONES ..321
AGREEMENTS 322
TECHNOLOGIES/PRODUCTS323
KEY FINANCIAL DATA325
TORNIER 327
KEY PERSONNEL..327
COMPANY OVERVIEW .327
KEY MILESTONES 327
AGREEMENTS.328
R&D MILESTONES ..328
TECHNOLOGIES/PRODUCTS329
KEY FINANCIAL DATA333
TRANS1.. 335
KEY PERSONNEL..335
COMPANY OVERVIEW .335
KEY COMPETITORS 335
KEY MILESTONES 335
AGREEMENTS.336
TECHNOLOGIES/PRODUCTS336
KEY FINANCIAL DATA337
WRIGHT MEDICAL GROUP 339
KEY PERSONNEL..339
COMPANY OVERVIEW .339
KEY COMPETITORS 339
KEY MILESTONES 339
AGREEMENTS.341
R&D MILESTONES ..341
TECHNOLOGIES/PRODUCTS342
KEY FINANCIAL DATA349
X-SPINE SYSTEMS.351
KEY PERSONNEL..351
COMPANY OVERVIEW .351
KEY MILESTONES 351
AGREEMENTS.351
TECHNOLOGIES/PRODUCTS352
KEY FINANCIAL DATA353
ZIMMER. 355
KEY PERSONNEL..355
COMPANY OVERVIEW .355
KEY COMPETITORS355
KEY MILESTONES 355
AGREEMENTS.357
R&D MILESTONES ..358
TECHNOLOGIES/PRODUCTS359
KEY FINANCIAL DATA368
To order this report:
Orthopedic Industry: Orthopaedics: Market Prospects & Global Competition
Contact Nicolas: [email protected]
US: (805)-652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article